A large new study links common IBS drugs like loperamide and diphenoxylate to a higher risk of death. Experts say the risk is ...

LSL PHARMA GROUP INC. (TSXV: LSL) ("LSL Pharma" or the "Company"), a Canadian integrated pharmaceutical company, today announced the signing of a binding term sheet with Instapill Private Limited ...

A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly ...

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...

Several of the most common treatments for irritable bowel syndrome could raise the risk of death, a study from researchers at ...

Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. | Drug Discovery And Development ...

A long-term study links some IBS drugs, including antidepressants and anti-diarrhoeals, to a small increased death risk, ...

Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person’s risk of early death.

Research indicates that antidepressant use in IBS is linked to a 35% higher risk of all-cause mortality, highlighting safety issues with long-term treatment.